MHRA updates guidance for GLP-1 prescribers and patients
About a third of people on cagrilintide (31.6%) achieved 15% weight loss or more, compared to roughly 1 in 20 (4.7%) on placebo
Tesamorelin Used for patients whose evaluation supports growth hormone secretagogue therapy with a specific focus on visceral fat and metabolic health
Due to its sulfur content, NAC is able to disrupt disulfide bonds, thinning the mucus so that it, along with the trapped particles and bacteria, are more easily expelled from the lungs
Dosing protocols are highly individualized and should be managed by a clinician with experience in peptide therapy and the specific indication being treated
The arginine salt formulation shows only 15.1% degradation after 5 hours at pH 3.0, compared to 99% destruction of standard acetate forms under the same conditions